Featured
-
-
Article |
Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study
- Renata Abrahão
- , Ann Brunson
- & Theresa H. M. Keegan
-
Article |
Treatment interval in curative treatment of colon cancer, does it impact (cancer free) survival? A non-inferiority analysis
- Maud T. A. Strous
- , Charlotte J. L. Molenaar
- & F. Jeroen Vogelaar
-
Article |
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis
- Mateus Trinconi Cunha
- , Mariana Carvalho Gouveia
- & Renata Colombo Bonadio
-
Article
| Open AccessApalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
- John Shen
- , Simon Chowdhury
- & Julie N. Graff
-
Article |
Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence
- Ying Hou
- , Ke-Wen Jiang
- & Yu-Dong Zhang
-
Article
| Open AccessDifferential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
- N. M. Atallah
- , M. Alsaleem
- & E. Rakha
-
Article |
Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme
- Tim L. Kortlever
- , Manon van der Vlugt
- & Evelien Dekker
-
Article
| Open AccessA tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events
- Helena J. Janse van Rensburg
- , Zhihui Liu
- & Aaron R. Hansen
-
Article |
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours
- Hyung-Don Kim
- , Changhoon Yoo
- & Yoon-Koo Kang
-
Article |
Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)
- Seohyuk Lee
- , Chao Ma
- & Jeffrey A. Meyerhardt
-
Article
| Open AccessTemporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study
- Jeffrey Shi Kai Chan
- , Danish Iltaf Satti
- & Chi Fai Ng
-
Article |
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and non-small cell lung cancer survival
- Juhua Luo
- , Michael Hendryx
- & Yi Dong
-
Article
| Open AccessPrognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases
- Michele Bottosso
- , Gaia Griguolo
- & Maria Vittoria Dieci
-
Article
| Open AccessIntratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma
- Magnus Kock am Brink
- , Laura Sophie Dunst
- & Christoph Röcken
-
Article |
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
- Tatiana Georgiesh
- , Ninna Aggerholm-Pedersen
- & Kjetil Boye
-
Article
| Open AccessConfidence bands in survival analysis
- Michael C. Sachs
- , Adam Brand
- & Erin E. Gabriel
-
Article
| Open AccessBreast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
- Julia Tutzauer
- , Martin Sjöström
- & Annika Jögi
-
Article |
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
- Sonia Zaibet
- , Vincent Hautefeuille
- & Simon Pernot
-
Article |
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns
- Nouredin Messaoudi
- , David Henault
- & Simon Turcotte
-
Article |
Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy
- Chengshi Wang
- , Kejia Hu
- & Donghao Lu
-
Article
| Open AccessLong-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
- Maartje van Seijen
- , Esther H. Lips
- & Michael Schaapveld
-
Article |
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study
- Jia-Li Feng
- , Suzanne C. Dixon-Suen
- & Penelope M. Webb
-
Article |
Post-diagnostic coffee and tea consumption and breast cancer survival
- Maryam S. Farvid
- , Nicholas D. Spence
- & Michelle D. Holmes
-
Article
| Open AccessRecovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
- Alejandra Castanon
- , Matejka Rebolj
- & Peter Sasieni
-
Article
| Open AccessSystemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases
- Angelika M. Starzer
- , Ariane Steindl
- & Anna S. Berghoff
-
Article
| Open AccessNatural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
- Min Yuen Teo
- , Hikmat Al-Ahmadie
- & Jonathan E. Rosenberg
-
Article
| Open AccessComputed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia
- Victoria L. Parker
- , Matthew C. Winter
- & Robert F. Harrison
-
Brief Communication
| Open AccessThe COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020
- Toral Gathani
- , Gill Clayton
- & Kieran Horgan
-
Article
| Open AccessThe Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer
- Peter G. Alexander
- , Antonia K. Roseweir
- & James H. Park
-
Article
| Open AccessThe effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials
- Peter G. Vaughan-Shaw
- , Louis F. Buijs
- & Malcolm G. Dunlop
-
Article
| Open AccessVascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
- Johannes Stelwagen
- , Sjoukje Lubberts
- & Jourik A. Gietema
-
Article
| Open AccessOne-year mortality of colorectal cancer patients: development and validation of a prediction model using linked national electronic data
- Thomas E. Cowling
- , Alexis Bellot
- & Jan van der Meulen
-
Article
| Open AccessPhase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial
- Angelos Koutras
- , Flora Zagouri
- & George Fountzilas
-
Article
| Open AccessFatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
- Dimitrios A. Koutoukidis
- , Joanne Land
- & Kwee L. Yong
-
Article
| Open AccessImmune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
- Vincent Ting Fung Cheung
- , Tarun Gupta
- & Oliver Brain
-
Article
| Open AccessSurvival benefit of tamoxifen in male breast cancer: prospective cohort analysis
- Holm Eggemann
- , Cosima Brucker
- & Atanas Ignatov
-
Article
| Open AccessCovariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma
- Andrew Briggs
- , Bruno Daniele
- & Gabriel Tremblay
-
Article
| Open AccessSurvival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients
- Hayley S. McKenzie
- , Tom Maishman
- & Ellen Copson
-
Article
| Open AccessProgression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
- Lisa Belin
- , Aidan Tan
- & Agnès Dechartres
-
Article
| Open AccessImpact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
- Amélie Darlix
- , Guillaume Louvel
- & Thomas Bachelot
-
Article
| Open AccessOverall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
- Magali Rouyer
- , Stéphane Oudard
- & Laurent Vives
-
Brief Communication
| Open AccessIn utero exposure to breast cancer treatment: a population-based perinatal outcome study
- Nadom Safi
- , Antoinette Anazodo
- & Elizabeth A. Sullivan
-
Review Article
| Open AccessThe relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues
- Elena Campello
- , Anton Ilich
- & Nigel S. Key
-
Article
| Open AccessUnderstanding the impact of socioeconomic differences in colorectal cancer survival: potential gain in life-years
- Elisavet Syriopoulou
- , Eva Morris
- & Mark J. Rutherford
-
Article
| Open AccessThe impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study
- Rachel L O’Connell
- , Tim Rattay
- & Mohammed Mustafa
-
Correspondence
| Open AccessComment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis"
- Hélène Péré
- , Juliette Pavie
- & Cécile Badoual
-
Article
| Open AccessIntensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours
- Fieke E. M. Froeling
- , Ramya Ramaswami
- & Michael J. Seckl
-
Correspondence |
Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
- Frederikus A. Klok
- , Henri H. Versteeg
- & Menno V. Huisman
-
Article
| Open AccessTamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis
- Holm Eggemann
- , Anna-Lena Bernreiter
- & Atanas Ignatov